Research programme: cyclin-dependent kinase 9 inhibitors - Vichem Chemie
Latest Information Update: 05 Jul 2016
At a glance
- Originator Vichem Chemie
- Developer Vichem Chemie; Virostatics
- Mechanism of Action Cyclin dependent kinase 9 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 05 Jul 2016 Preclinical trials in HIV infections in Hungary (unspecified route)